title: Session 4.2: Viral Spiking, Viral Preparation, and Upstream Risk Mitigation Strategies.
authors: Process Virology/Purification Development Department. Genentech, a Member of the Roche Group, 1 DNA Way, MS10, South San Francisco, CA 94080; and meisam.bakhshayeshi@biogen.com.
authors: Meisam
authors: M
authors: Bakhshayeshi
authors: Senior Engineer, Biogen, 225 Binney Street, Cambridge, MA 02142.
authors: Rachel
authors: R
authors: Specht
mesh_terms: D012306:Risk; D014780:Viruses / Q000302:isolation & purification*